Estimating The Economic Consequences Of An Increased Medication Compliance Due To A Potential Improvement Of The Inhaler Technique With Spiromax® Compared With Turbuhaler® In Moderate To Severe Patients With Copd In Spain

Nov 1, 2015, 00:00 AM
Section Title : Research Podium Presentations - Session 1 and Session 2
Section Order : 73
First Page : A348
HEOR Topics :
Tags :
Regions :